Bon Natural Life (BON) Competitors $1.40 -0.10 (-6.54%) As of 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrends BON vs. ORGS, RDHL, VIRX, ABVC, APM, CNSP, GLTO, KZIA, ADIL, and GRIShould you be buying Bon Natural Life stock or one of its competitors? The main competitors of Bon Natural Life include Orgenesis (ORGS), RedHill Biopharma (RDHL), Viracta Therapeutics (VIRX), ABVC BioPharma (ABVC), Aptorum Group (APM), CNS Pharmaceuticals (CNSP), Galecto (GLTO), Kazia Therapeutics (KZIA), Adial Pharmaceuticals (ADIL), and GRI Bio (GRI). These companies are all part of the "pharmaceutical products" industry. Bon Natural Life vs. Orgenesis RedHill Biopharma Viracta Therapeutics ABVC BioPharma Aptorum Group CNS Pharmaceuticals Galecto Kazia Therapeutics Adial Pharmaceuticals GRI Bio Orgenesis (NASDAQ:ORGS) and Bon Natural Life (NYSE:BON) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk. Does the MarketBeat Community favor ORGS or BON? Orgenesis received 1 more outperform votes than Bon Natural Life when rated by MarketBeat users. CompanyUnderperformOutperformOrgenesisOutperform Votes1100.00% Underperform VotesNo VotesBon Natural LifeN/AN/A Which has more volatility & risk, ORGS or BON? Orgenesis has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500. Comparatively, Bon Natural Life has a beta of -1.09, indicating that its share price is 209% less volatile than the S&P 500. Is ORGS or BON more profitable? Bon Natural Life has a net margin of 0.00% compared to Orgenesis' net margin of -3,827.81%. Company Net Margins Return on Equity Return on Assets Orgenesis-3,827.81% N/A -130.18% Bon Natural Life N/A N/A N/A Which has preferable earnings and valuation, ORGS or BON? Bon Natural Life has higher revenue and earnings than Orgenesis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrgenesis$530K15.31-$55.36MN/AN/ABon Natural Life$29.52M0.06$4.60MN/AN/A Do insiders & institutionals hold more shares of ORGS or BON? 22.6% of Orgenesis shares are held by institutional investors. Comparatively, 0.6% of Bon Natural Life shares are held by institutional investors. 5.7% of Orgenesis shares are held by insiders. Comparatively, 26.5% of Bon Natural Life shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media refer more to ORGS or BON? In the previous week, Orgenesis' average media sentiment score of 0.00 equaled Bon Natural Life'saverage media sentiment score. Company Overall Sentiment Orgenesis Neutral Bon Natural Life Neutral SummaryBon Natural Life beats Orgenesis on 5 of the 9 factors compared between the two stocks. Get Bon Natural Life News Delivered to You Automatically Sign up to receive the latest news and ratings for BON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BON vs. The Competition Export to ExcelMetricBon Natural LifeMedicinals & botanicals IndustryDiscretionary SectorNYSE ExchangeMarket Cap$1.63M$1.19B$8.47B$20.05BDividend YieldN/AN/A2.85%3.61%P/E RatioN/A35.4114.6241.75Price / Sales0.065.886.6917.51Price / Cash0.309.9815.3917.54Price / Book0.052.086.035.86Net Income$4.60M-$53.10M$274.28M$1.01B7 Day Performance-14.42%-0.04%2.23%3.59%1 Month Performance-5.10%-0.64%2.62%6.09%1 Year Performance-73.47%-4.80%12.26%20.27% Bon Natural Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BONBon Natural LifeN/A$1.40-6.5%N/A-71.6%$1.63M$29.52M0.00100ORGSOrgenesisN/A$1.62-10.0%N/AN/A$7.77M$662,000.000.00150Gap DownRDHLRedHill Biopharma0.2042 of 5 stars$5.62-4.1%N/A-99.0%$7.20M$3.71M-0.56210News CoveragePositive NewsVIRXViracta Therapeutics3.3069 of 5 stars$0.18-3.3%$4.05+2,152.5%-66.9%$7.15MN/A-0.1620ABVCABVC BioPharma0.9114 of 5 stars$0.53-4.3%N/A-56.8%$6.86M$509,788.00-0.6230Positive NewsGap DownAPMAptorum Group0.9011 of 5 stars$1.32-5.0%N/A-32.4%$6.84M$431,378.000.0030Gap UpCNSPCNS Pharmaceuticals2.6955 of 5 stars$0.12+0.3%$0.50+323.4%-99.7%$6.79MN/A0.005News CoveragePositive NewsGLTOGalecto3.3256 of 5 stars$5.09-0.8%$10.00+96.5%-68.1%$6.70MN/A-0.2740KZIAKazia Therapeutics3.7731 of 5 stars$1.52-3.8%$20.00+1,215.9%-59.6%$6.62M$2.31M0.0012ADILAdial Pharmaceuticals3.1598 of 5 stars$1.02-0.5%$8.00+688.2%-24.7%$6.50MN/A0.0020Positive NewsGap DownGRIGRI Bio2.7789 of 5 stars$0.72-5.6%$11.50+1,497.2%-97.1%$6.43MN/A-0.771Positive News Related Companies and Tools Related Companies Orgenesis Competitors RedHill Biopharma Competitors Viracta Therapeutics Competitors ABVC BioPharma Competitors Aptorum Group Competitors CNS Pharmaceuticals Competitors Galecto Competitors Kazia Therapeutics Competitors Adial Pharmaceuticals Competitors GRI Bio Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:BON) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bon Natural Life Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Bon Natural Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BON Stock Alerts